2012•European Journal of Nuclear Medicine and Molecular ImagingRequires access

Feasibility of bremsstrahlung dosimetry for direct dose estimation in patients undergoing treatment with 90Y-ibritumomab tiuxetan

Cecilia Arrichiello, Luigi Aloj, M. Mormile, Laura D’Ambrosio, Ferdinando Frigeri, Corrado Caracò, Manuela Arcamone, Francesco De Martinis, Antonio Pinto, Secondo Lastoria

Open publisher page 3 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ibritumomab tiuxetan, Dosimetry, Radioimmunotherapy, Nuclear medicine, Medicine, Absorbed dose, Immunology, Monoclonal antibody